Global push to fight childhood obesity in poorer urban areas
NCT ID NCT06855563
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests community-based programs in six countries to help children ages 6-13 eat healthier and be more active. The goal is to prevent obesity and improve quality of life in disadvantaged urban communities. Researchers will track changes in body mass index and health-related quality of life over two years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
community-based intervention packages (diet and physical activity programs)
What this could lead to
If successful, this could provide effective, community-driven strategies to prevent childhood obesity and improve health in disadvantaged urban areas worldwide.
What could go wrong
This is a large observational study without a control group, so results may be influenced by other factors. The interventions vary by city, making it hard to pinpoint what works best.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novo Nordisk - Türkiye
Bangalore, 560066, Brazil
-
Novo Nordisk - Türkiye
Bangalore, 560066, Japan
-
Novo Nordisk Investigational Site
Loagan, Australia
-
Novo Nordisk Investigational Site
Mississauga, Canada
-
Novo Nordisk Investigational Site
Johannesburg, South Africa
-
Novo Nordisk Investigational Site
Madrid, Spain